Products for Research Use Only
RegisterLogin

Neomycin

CAT: 0804-HY-150520Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-150520Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Neomycin is an aminoglycoside antibiotic. Neomycin can be used for the research of external or internal bacterial infections, is primarily administered in veterinary medicine as a sulfate salt[1].
CAS Number
1404-04-2
UNSPSC
12352100
Hazard Statement
H361-H373
Target
Antibiotic
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection; Cancer
Assay Protocol
https://www.medchemexpress.com/neomycin.html
Solubility
10 mM in DMSO
Smiles
[Neomycin]
Precautions
P260-P280-P405-P501
References & Citations
[1]Liu Y, et al. Pharmacokinetics of neomycin sulfate after intravenous and oral administrations in swine. J Vet Pharmacol Ther. 2021 Sep;44 (5) :850-853.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
Launched
Citation 01
Adv Sci (Weinh) . 2025 Apr 28:e2409837.|Genome Biol. 2023 Apr 30;24 (1) :98.|iScience. 2025 May 13;28 (7) :112658.|iScience. 2025 May 27;28 (6) :112763.|J Agric Food Chem. 2024 Apr 10.|Neoplasia. 2024 Jan:47:100963.|Neural Regen Res. 2024 Sep 1;19 (9) :2081-2088.|Adv Sci (Weinh) . 2025 Apr;12 (16) :e2415041.|Adv Sci (Weinh) . 2025 Mar 31:e2416348.|Adv Sci (Weinh) . 2025 Oct 13:e09383.|Am J Chin Med. 2024 Aug 21:1-28.|Aquaculture. 2021, 736248.|Biochem Biophys Res Commun. 2025 Jun 7:776:152161.|Biochem Pharmacol. 2024 Dec;230 (Pt 2) :116593.|Brain Behav Immun. 2021 Feb:92:102-114.|Cancer Cell. 2025 Sep 25:S1535-6108 (25) 00394-0.|Cancer Immunol Res. 2022 Dec 2;10 (12) :1542-1558.|Cancer Res. 2025 Jul 2;85 (13) :2468-2484.|Cell Biochem Biophys. 2025 Oct 31.|Cell Death Dis. 2021 Jun 7;12 (6) :582.|Cell Death Discov. 2022 Feb 22;8 (1) :77.|Cell Metab. 2023 Nov 7;35 (11) :1961-1975.e6.|Cell Metab. 2025 Jan 7;37 (1) :87-103.e10.|Cell Rep Med. 2024 Sep 21:101753.|Cell Rep. 2021 Sep 7;36 (10) :109660.|Cell Rep. 2023 Dec 27;43 (1) :113591.|Clin Transl Med. 2024 Oct;14 (10) :e70038.|CNS Neurosci Ther. 2025 Feb;31 (2) :e70253.|EMBO Rep. 2024 Nov;25 (11) :4827-4845.|Emerg Microbes Infect. 2022 Dec;11 (1) :815-828.|Exp Neurol. 2025 Jan 8:385:115142.|Food Funct. 2025 Jul 14;16 (14) :5885-5899.|Front Aging Neurosci. 2022 Jul 28;14:858130.|Gut Microbes. 2023 Dec;15 (2) :2249143.|Gut Microbes. 2023 Dec;15 (2) :2282790.|Gut Microbes. 2024 Jan-Dec;16 (1) :2390164.|Int J Biol Macromol. 2024 Sep 19:135835.|J Cell Physiol. 2022 Mar;237 (3) :1845-1856.|J Nanobiotechnology. 2024 Apr 8;22 (1) :157.|J Nanobiotechnology. 2025 Jun 13;23 (1) :443.|J Pineal Res. 2024 Apr;76 (3) :e12954.|Life Metab. 2025 Oct 8.|Life Sci. 2020 Nov 15;261:118473.|Microbiologyopen. 2019 Oct;8 (10) :e873.|Mol Cell Biochem. 2021 Jun;476 (6) :2503-2512.|Mol Immunol. 2022 Sep:149:94-106.|Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398 (4) :3681-3695.|Neurotherapeutics. 2023 Sep;20 (5) :1405-1426.|NPJ Biofilms Microbiomes. 2024 Oct 28;10 (1) :111.|Nutrients. 2023 Oct 18;15 (20) :4427.|Pharmacol Res. 2024 May 21:205:107229.|Res Sq. 2024 Oct 02.|Research (Wash D C) . 2024 Jul 16:7:0415.|Sci Adv. 2023 Feb 17;9 (7) :eade4770.|SSRN. 2023 Sep 11.|STAR Protoc. 2025 Jan 23;6 (1) :103585.|Water. 2025 Jun 6.

Alternative Products

CatalogName
RM-N150303-01Neomycin
JL17569-01Neomycin (Neomycin) ELISA Kit
GTR18867526-01General Neomycin (Neomycin) ELISA Kit
B1795-5.1Neomycin sulfate
C53MR1070-50Neomycin, NEO
80-1471Neomycin-BSA
FN175622Neomycin B
052657-01Neomycin (NMC)
227091Neomycin (HRP)
T73953-01Neomycin C

Popular Products